Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
Recruiting · NCT06680050 · Registry updated 2025-12-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen | Non Small Cell Lung Cancer NSCLC | Recruiting | Phase 2 | 2025-12-18 | NCT06680050 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mario Negri Institute for Pharmacological Research | 51 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ASST degli Spedali Civili di Brescia | Brescia | Italy | 9 |
| ASST Grande Ospedale Metropolitano Niguarda | Milan | Italy | 29 |
| Azienda Ospedaliera di Padova | Padova | Italy | 15 |
| Azienda Ospedaliero - Universitaria di Parma | Parma | Italy | 1 |
| Azienda Ospedaliero Universitaria Careggi | Florence | Italy | 11 |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan | Italy | 26 |
| IRCCS Ospedale Policlinico San Martino, Genova | Genova | Italy | 1 |
| University Hospital of Geneva | Geneva | Switzerland | 3 |
| University Hospital Zurich | Zurich | Switzerland | 25 |